{"slug":"tirzepatide-neuropathy","verification":{"valid":true,"entries":2,"head":"7102eae35b370a00387f1610ec870af28524740e1b45bfb08361f1d7503efd9f"},"energy":{"passes":2,"tokens_in":15592,"tokens_out":2598,"tokens_total":18190,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"7102eae35b370a00387f1610ec870af28524740e1b45bfb08361f1d7503efd9f"},"provenance":[{"ts":"2026-06-29T22:43:46.144Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tirzepatide for Neuropathy\nSlug: tirzepatide-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tirzepatide\",\"name\":\"Tirzepatide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tirzepatide\",\"name\":\"Tirzepatide\",\"section_title\":\"Why Tirzepatide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\",\"**What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\",\"**Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n2. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n3. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition ","response":"{\n  \"slug\": \"tirzepatide-neuropathy\",\n  \"title\": \"Tirzepatide for Neuropathy: Metabolic Load Reduction and Observed Nerve Changes\",\n  \"body\": \"## What's breaking down\\n\\nNeuropathy often involves degeneration where repair pathways fall behind damage from sustained high blood sugar, excess body weight, and related inflammation. In people carrying extra weight, each additional pound can add roughly four pounds of compressive force across the lower spine and joints, increasing mechanical stress on peripheral nerves. Hyperglycemia further damages small nerve fibers over time. When these layers overlap, symptoms like tingling, numbness, or pain persist because breakdown outpaces natural regeneration.\\n\\nTirzepatide is studied primarily for its effects on weight and blood glucose rather than direct nerve repair. The discussion below focuses on how its documented actions on metabolic load might intersect with neuropathy layers.\\n\\n## Why Tirzepatide might help you\\n\\n1. **What keeps failing:** The same mechanical overload pattern seen in other GLP-1 contexts appears when body weight stays elevated. Extra mass increases pressure on nerves and joints, while poor glycemic control adds direct metabolic damage to nerve fibers.\\n\\n2. **What Tirzepatide is studied to do:** It is studied for dual GLP-1 and GIP receptor agonism that produces substantial weight loss and improved glycemic control. Human trials show average reductions of 15–20 percent body weight over 72 weeks alongside HbA1c drops of 2 percentage points or more.\\n\\n3. **Therefore for you:** If mechanical overload or sustained hyperglycemia forms part of your neuropathy picture, Tirzepatide is discussed because it targets those upstream factors. Weight reduction can lower compressive forces on nerves; better glucose control may slow further metabolic damage. This is framed as supporting repair pathways rather than masking symptoms.\\n\\n## How these fit together\\n\\nSingle-compound focus. Tirzepatide maps to the metaboli","tokens_in":15592,"tokens_out":2598,"cost":0,"prev":"genesis","hash":"c22f1a76a356cc20d4e71aee7cef36f76293b2c86a875026d1da3deabc40e224"},{"ts":"2026-07-17T02:43:17.931Z","model":"owner","action":"voxel_divide","prompt":"","input":"tirzepatide-neuropathy","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c22f1a76a356cc20d4e71aee7cef36f76293b2c86a875026d1da3deabc40e224","hash":"7102eae35b370a00387f1610ec870af28524740e1b45bfb08361f1d7503efd9f"}]}